Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial (Q34654493)

3 August 2017

title

Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial (English)

1 reference

randomized controlled trial

3 August 2017

0 references

1 reference

1

Kristine Yaffe

1 reference

3 August 2017

5

Age-Related Eye Disease Study Research Group

1 reference

3 August 2017

Traci E Clemons

2

1 reference

3 August 2017

Wendy L McBee

series ordinal

3

1 reference

3 August 2017

Anne S Lindblad

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

3 August 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

Neurology

1 reference

3 August 2017

volume

63

1 reference

3 August 2017

issue

9

1 reference

3 August 2017

page(s)

1705-1707

1 reference

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Rapid induction of Alzheimer A beta amyloid formation by zinc.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Antioxidant vitamin intake and risk of Alzheimer disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Elevation of serum copper levels in Alzheimer's disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Dietary intake of antioxidants and risk of Alzheimer disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1473037

10.1212/01.WNL.0000142969.19465.8F

26 October 2018

Identifiers

DOI

1 reference

release_pmvud3offrgoxesltjoh4jeipy

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pmvud3offrgoxesltjoh4jeipy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

1473037

1 reference

3 August 2017

1 reference